# Novel mGluR5 Modulator Effects on Alcohol Drinking and MRI Outcomes

> **NCT04831684** · PHASE1,PHASE2 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 79 (actual)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Placebo
- **DRUG:** GET73

## Key facts

- **NCT ID:** NCT04831684
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-15
- **Primary completion:** 2025-12-29
- **Final completion:** 2025-12-29
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2026-02-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04831684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04831684, "Novel mGluR5 Modulator Effects on Alcohol Drinking and MRI Outcomes". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT04831684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*